furosemide has been researched along with deamino arginine vasopressin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.88) | 18.7374 |
| 1990's | 4 (23.53) | 18.2507 |
| 2000's | 8 (47.06) | 29.6817 |
| 2010's | 4 (23.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Albano, JD; Bhatia, SS; Campbell, SK; Millar, JG; Waller, DG | 1 |
| Blot-Chabaud, M; Bonvalet, JP; Farman, N; Jaisser, F; Pradelles, P | 1 |
| Albrecht, GJ; Beck, FX; Dörge, A; Sone, M; Thurau, K | 1 |
| Corapçioğlu, D; Erdoğan, G; Erdoğan, MF; Hallioğlu, J; Uysal, AR | 1 |
| Fucharoen, S; Malasit, P; Nilwarangkur, S; Ong-ajyooth, L; Ong-ajyooth, S; Pootrakul, P; Siritanaratkul, N; Vasuvattakul, S | 1 |
| Baumgarten, R; Deen, PM; van de Pol, MH; van Os, CH; Wetzels, JF | 1 |
| Gourgiotis, D; Karpathios, T; Kavazarakis, E; Moustaki, M; Nakopoulou, L; Zeis, MP; Zeis, PM | 1 |
| Bailly, P; Cartron, JP; Gane, P; Lasbennes, F; Ripoche, P; Roudier, N; Trinh-Trang-Tan, MM | 1 |
| Hansson, S; Johansson, E; Nevéus, T | 1 |
| Arata, T; Ejima, Y; Hatano, R; Kazama, I; Matsubara, M; Michimata, M; Miyama, N; Sasaki, S; Sato, A; Satomi, S; Suzuki, K; Suzuki, M | 1 |
| Hansson, S; Johansson, E; Nevéus, T; Nydahl-Persson, K; Peterson, H | 1 |
| De Guchtenaere, A; Dehoorne, J; Donckerwolcke, R; Hoebeke, P; Raes, A; Van Laecke, E; Van Sintjan, P; Vande Walle, C; Vande Walle, J | 1 |
| Bankir, L; Bardoux, P; Bichet, DG; Bouby, N; Perucca, J | 1 |
| Morimoto, Y; Shibata, Y | 1 |
| Fu, FG; Lavery, HJ; Wu, DL | 1 |
| Golosova, DV; Karavashkina, TA; Kutina, AV; Marina, AS; Natochin, YV | 1 |
1 review(s) available for furosemide and deamino arginine vasopressin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
5 trial(s) available for furosemide and deamino arginine vasopressin
| Article | Year |
|---|---|
Active and inactive urinary kallikrein in man: effects of diuresis and antidiuresis.
Topics: Adult; Deamino Arginine Vasopressin; Diuresis; Female; Furosemide; Humans; Kallikreins; Male; Osmolar Concentration; Time Factors; Urination; Water | 1990 |
Diuretic treatment of nocturnal enuresis: preliminary results of an open pilot study.
Topics: Adolescent; Child; Child, Preschool; Deamino Arginine Vasopressin; Diuretics; Enuresis; Female; Furosemide; Humans; Male; Pilot Projects; Renal Agents; Time Factors | 2004 |
Diuretic treatment of nocturnal enuresis.
Topics: Administration, Oral; Adolescent; Antidiuretic Agents; Child; Child, Preschool; Deamino Arginine Vasopressin; Diuretics; Drug Administration Schedule; Enuresis; Female; Follow-Up Studies; Furosemide; Humans; Male; Treatment Outcome; Urodynamics | 2005 |
Desmopressin resistant nocturnal polyuria may benefit from furosemide therapy administered in the morning.
Topics: Child; Deamino Arginine Vasopressin; Diuresis; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Furosemide; Humans; Male; Nocturnal Enuresis; Pilot Projects; Polyuria; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome; Urination; Urodynamics | 2007 |
Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin.
Topics: Age Factors; Aged; Aged, 80 and over; China; Deamino Arginine Vasopressin; Diuretics; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Furosemide; Humans; Male; Middle Aged; Nocturia; Placebo Effect; Sleep; Time Factors; Treatment Outcome; Urodynamics | 2011 |
11 other study(ies) available for furosemide and deamino arginine vasopressin
| Article | Year |
|---|---|
Antidiuretic hormone reduces the high PGE2 synthesis in papillary collecting duct of DI rats.
Topics: Animals; Deamino Arginine Vasopressin; Diabetes Insipidus; Dinoprostone; Diuresis; Female; Furosemide; Kidney Medulla; Kidney Tubules; Kidney Tubules, Collecting; Loop of Henle; Nephrons; Osmolar Concentration; Oxytocin; Rats; Rats, Brattleboro; Urine; Vasopressins | 1989 |
Osmotic adaptation of renal medullary cells during transition from chronic diuresis to antidiuresis.
Topics: Alanine; Animals; Aspartic Acid; Chlorides; Chromatography, High Pressure Liquid; Cryoultramicrotomy; Deamino Arginine Vasopressin; Diuresis; Electron Probe Microanalysis; Furosemide; Glutamates; Glutamic Acid; Glycine; Kidney Medulla; Male; Methylamines; Osmosis; Polymers; Potassium; Rats; Rats, Wistar; Sodium; Taurine; Urea | 1993 |
Furosemide and dDAVP for the treatment of pseudohypoaldosteronism type II.
Topics: Adult; Deamino Arginine Vasopressin; Diuretics; Follow-Up Studies; Furosemide; Humans; Male; Pseudohypoaldosteronism; Renal Agents | 1997 |
Renal function in adult beta-thalassemia/Hb E disease.
Topics: Acetylglucosaminidase; Adult; Ammonia; beta 2-Microglobulin; beta-Thalassemia; Bicarbonates; Creatinine; Deamino Arginine Vasopressin; Diuretics; Erythrocyte Count; Female; Ferritins; Furosemide; Hemoglobin E; Hemoglobinopathies; Humans; Hydrogen-Ion Concentration; Kidney; Male; Malondialdehyde; Osmolar Concentration; Proteinuria; Renal Agents; Renal Aminoacidurias; Splenectomy; Thailand; Urea; Water Deprivation | 1998 |
Dissociation between urine osmolality and urinary excretion of aquaporin-2 in healthy volunteers.
Topics: Adult; Aquaporin 2; Aquaporin 6; Aquaporins; Deamino Arginine Vasopressin; Dehydration; Diuretics; Female; Furosemide; Humans; Male; Osmolar Concentration; Reference Values; Renal Agents; Saline Solution, Hypertonic; Urine | 2000 |
Protective effect of poly I:poly C from gentamicin nephrotoxicity in guinea pigs.
Topics: Animals; Deamino Arginine Vasopressin; Drug Administration Schedule; Drug Combinations; Furosemide; Gentamicins; Guinea Pigs; Kidney; Male; Poly I-C | 2001 |
UT-B1 proteins in rat: tissue distribution and regulation by antidiuretic hormone in kidney.
Topics: Amino Acid Sequence; Animals; Astrocytes; Carrier Proteins; Deamino Arginine Vasopressin; Diuretics; Down-Regulation; Erythrocytes; Furosemide; Glycosylation; Humans; Immunohistochemistry; Kidney; Kidney Medulla; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Molecular Sequence Data; Rabbits; Rats; Rats, Sprague-Dawley; Renal Agents; Species Specificity; Urea Transporters; Vasopressins | 2002 |
BSC1 inhibition complements effects of vasopressin V2 receptor antagonist on hyponatremia in SIADH rats.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Aquaporin 2; Aquaporins; Benzazepines; Deamino Arginine Vasopressin; Diuretics; Furosemide; Hyponatremia; Inappropriate ADH Syndrome; Kidney Medulla; Male; Potassium; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Sodium; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Potassium-Chloride Symporters; Solute Carrier Family 12, Member 1; Urea; Water | 2005 |
Sodium excretion in response to vasopressin and selective vasopressin receptor antagonists.
Topics: Animals; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Deamino Arginine Vasopressin; Diuretics; Dose-Response Relationship, Drug; Furosemide; Male; Morpholines; Rats; Rats, Wistar; Receptors, Vasopressin; Sodium; Spiro Compounds; Urine | 2008 |
Effects of various fragrant ingredients on desmopressin-induced fluid retention in mice.
Topics: Animals; Aromatherapy; Cyclohexenes; Deamino Arginine Vasopressin; Disease Models, Animal; Diuretics; Dose-Response Relationship, Drug; Edema; Furosemide; Guaiacol; Limonene; Male; Mice; Mice, Inbred Strains; Terpenes | 2010 |
Effects of Selective Agonists of V1a, V2, and V1b Receptors on Sodium Transport in Rat Kidney.
Topics: Animals; Biological Transport; Deamino Arginine Vasopressin; Diuretics; Drug Evaluation, Preclinical; Female; Furosemide; Kidney; Rats, Wistar; Receptors, Vasopressin; Sodium | 2016 |